|
1
|
Short K, Rajkumar S, Larson D, Buadi F,
Hayman S, Dispenzieri A, Gertz M, Kumar S, Mikhael J, Roy V, et al:
Incidence of extramedullary disease in patients with multiple
myeloma in the era of novel therapy, and the activity of
pomalidomide on extramedullary myeloma. Leukemia. 25:906–908.
2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Swerdlow SH, Campo E, Pileri SA, Harris
NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz
AD and Jaffe ES: The 2016 revision of the world health organization
classification of lymphoid neoplasms. Blood. 127:2375–2390.
2017.
|
|
3
|
Kyle RA and Rajkumar SV: Multiple myeloma.
N Engl J Med. 351:1860–73. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Byun JM, Kim KH, Choi IS, Park JH, Kim JS,
Shin DY, Koh Y, Kim I, Yoon SS and Lim HJ: Pleural effusion in
multiple myeloma: Characteristics and practice patterns. Acta
Haematol. 138:69–76. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wang Z, Xia G, Lan L, Liu F, Wang Y, Liu
B, Ding Y, Dai L and Zhang Y: Pleural effusion in multiple myeloma.
Intern Med. 55:339–345. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kintzer J, Rosenow EC III and Kyle RA:
Thoracic and pulmonary abnormalities in multiple myeloma. A review
of 958 Cases. Arch Intern Med. 138:727–730. 1978.PubMed/NCBI
|
|
7
|
Oudart JB, Maquart FX, Semouma O, Lauer M,
Arthuis-Demoulin P and Ramont L: Pleural effusion in a patient with
multiple myeloma. Clin Chem. 58:672–674. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bladé J, de Larrea CF, Rosiñol L, Cibeira
MT, Jiménez R and Powles R: Soft-tissue plasmacytomas in multiple
myeloma: Incidence, mechanisms of extramedullary spread, and
treatment approach. J Clin Oncol. 29:3805–3812. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Weinstock M and Ghobrial IM:
Extramedullary multiple myeloma. Leuk Lymphoma. 54:1135–1141.
2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
De Larrea CF, Rosiñol L, Cibeira MT,
Rozman M, Rovira M and Bladé J: Extensive soft-tissue involvement
by plasmablastic myeloma arising from displaced humeral fractures.
Eur J Haematol. 85:448–451. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Alexandrakis MG, Passam FH, Kyriakou DS
and Bouros D: Pleural effusions in hematologic malignancies. Chest.
125:1546–1555. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rodriguez J, Pereira A, Martínez JC, Conde
J and Pujol E: Pleural effusion in multiple myeloma. Chest.
105:622–624. 1994.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shirdel A, Attaran D, Ghobadi H and Ghiasi
T: Myelomatous pleural effusion. Tanaffos. 6:68–72. 2007.
|
|
14
|
Iqbal N, Tariq MU, Shaikh MU and Majid H:
Pleural effusion as a manifestation of multiple myeloma. BMJ Case
Rep. 12(bcr2016215433)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Light RW: The light criteria: The
beginning and why they are useful 40 years later. Clin Chest Med.
34:21–26. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bataiile R, Jégo G, Robillard N,
Barillé-Nion D, Harousseau JL, Moreau P, Amiot M and
Pellat-Deceunynck C: The phenotype of normal, reactive and
malignant plasma cells. Identification of ‘many and multiple
myelomas’ and of new targets for myeloma therapy. Haematologica.
91:1234–1240. 2006.PubMed/NCBI
|
|
17
|
Touzeau C and Moreau P: How I treat
extramedullary myeloma. Blood. 127:971–976. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Varga C, Xie W, Laubach J, Ghobrial IM,
O'Donnell EK, Weinstock M, Paba-Prada C, Warren D, Maglio ME,
Schlossman R, et al: Development of extramedullary myeloma in the
era of novel agents: No evidence of increased risk with
lenalidomide-bortezomib combinations. Br J Haematol. 169:843–850.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Usmani SZ, Heuck C, Mitchell A, Szymonifka
J, Nair B, Hoering A, Alsayed Y, Waheed S, Haider S, Restrepo A, et
al: Extramedullary disease portends poor prognosis in multiple
myeloma and is over-represented in high-risk disease even in the
era of novel agents. Haematologica. 97:1761–1767. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Havelock T, Teoh R, Laws D and Gleeson F:
BTS Pleural Disease Guideline Group. Pleural procedures and
thoracic ultrasound: British thoracic society pleural disease
guideline 2010. Thorax. 65 (Suppl 2):ii61–ii76. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kamble R, Wilson CS, Fassas A, Desikan R,
Siegel DS, Tricot G, Anderson P, Sawyer J, Anaissie E and Barlogie
B: Malignant pleural effusion of multiple myeloma: Prognostic
factors and outcome. Leuk Lymphoma. 46:1137–1142. 2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kim YJ, Kim SJ, Min K, Kim HY, Kim HJ, Lee
YK and Zang DY: Multiple myeloma with myelomatous pleural effusion:
A case report and review of the literature. Acta Haematol.
120:108–111. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Palmer HE, Wilson CS and Bardales RH:
Cytology and flow cytometry of malignant effusions of multiple
myeloma. Diagn Cytopathol. 22:147–151. 2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Iannitto E, Minardi V and Tripodo C: Use
of intrapleural bortezomib in myelomatous pleural effusion. Br J
Haematol. 139:621–622. 2007.PubMed/NCBI View Article : Google Scholar
|
